Question 1

What is the main problem with current liver cancer immunotherapy?

Accepted Answer

While immunotherapy is a primary treatment for advanced liver cancer, a significant number of patients experience primary or acquired resistance, limiting long-term success.

Question 2

What is the biggest clinical challenge in managing this resistance?

Accepted Answer

There is currently a lack of reliable, practical tools to predict which patients will develop resistance to immunotherapy before or during treatment.

Question 3

How can we improve patient outcomes?

Accepted Answer

Developing better predictive biomarkers and new interventional strategies is crucial to overcome immune resistance and tailor treatments to individual patients.

How Can We Overcome Immunotherapy Resistance in Advanced Liver Cancer (HCC)?